Page 2 - Stemcells Inc News Today

The Business Research Company covers the macular dege neration treatment market drivers and restraints, market size and the impact of COVID-19 on the market.

Microbot Medical (NASDAQ:MBOT – Get Rating) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Friday, Zacks.com reports. According to Zacks, “Microbot Medical Inc. is engaged in the research, design, development and commercialization of micro-robotics assisted medical technologies. Its product […]

Equities Research Analysts’ upgrades for Friday, April 22nd: American Airlines Group (NASDAQ:AAL) was upgraded by analysts at JPMorgan Chase & Co. from an underweight rating to a neutral rating. They currently have $26.00 price target on the stock, up from their previous price target of $18.00. American Airlines Group (NASDAQ:AAL) was upgraded by analysts at […]

Dublin, April 15, 2022 (GLOBE NEWSWIRE) -- The "Stem Cell Global Market Report 2022, By Source, By Product Type, By Application" report has been added to...

Zacks Investment Research upgraded shares of Microbot Medical (NASDAQ:MBOT – Get Rating) from a sell rating to a hold rating in a report published on Thursday morning, Zacks.com reports. According to Zacks, “Microbot Medical Inc. is engaged in the research, design, development and commercialization of micro-robotics assisted medical technologies. Its product candidate includes the Self […]

Vita Therapeutics, a cell engineering company harnessing the power of genetics to develop cellular therapies to treat muscular dystrophies and solid tumors, today announced the hiring of Amy Wesa, PhD, as Senior Vice President of Preclinical and Translational Research, Alexandra (Xana) Capela, PhD, as Senior Vice President of Regulatory and IND Strategy, and Michael Kuo as Senior Vice President of Manufacturing. In addition, Brown Advisory Chief Financial Officer and Chief Operating Officer Davi...

The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.

How did the FDA got browbeaten into approving an Alzheimer's drug that may not work?

Stem Cell Reconstructive Market Size 2021 By Analysis, Manufacturers, Regions, Type and Application, and Forecasts to 2023

Forecasts in US$ Million by Region/Country: 2020-2027 Table 2: Stem Cell Services Global Retrospective Market Scenario in US$ Million by Region/Country: 2012-2019 Table 3: Stem Cell Services Market Share Shift across Key Geographies Worldwide: 2012 VS 2020 VS 2027 Table 4: Service Based (Segment) World Market by Region/Country in US$ Million: 2020 to 2027 Table 5: Service Based (Segment) Historic Market Analysis by Region/Country in US$ Million: 2012 to 2019 Table 6: Service Based (Seg...